Study #2022-0869
A multi-arm, open-label phase I/IIa study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of AZD5305 in combination with new hormonal agents in patients with Metastatic Prostate Cancer (PETRANHA)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Patrick Pilie
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-855-581-8877
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.